Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status on the study page is updated to indicate no longer looking for participants, signaling that enrollment has ended. New guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and the page revision label was updated to v3.6.0 (replacing the previous v3.5.5).SummaryDifference0.6%

- Check17 days agoChange DetectedFooter revision updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor site update that does not affect the study details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record metadata.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page’s display footer was updated to reflect a newer ClinicalTrials.gov site revision (v3.5.3) instead of the previous (v3.5.2). This is a versioning/maintenance update rather than a change to the underlying study record details.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check96 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.